European Journal of Clinical Investigation

Cover image for Vol. 46 Issue 5

Edited By: John P.A. Ioannidis

Impact Factor: 2.734

ISI Journal Citation Reports © Ranking: 2014: 30/154 (Medicine General & Internal); 52/123 (Medicine Research & Experimental)

Online ISSN: 1365-2362

Virtual Issues

Virtual issue on Research Methodology

1) STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement (pages 1–16)
Valentina Gallo, Matthias Egger, Valerie McCormack, Peter B. Farmer, John P. A. Ioannidis, Micheline Kirsch-Volders, Giuseppe Matullo, David H. Phillips, Bernadette Schoket, Ulf Stromberg, Roel Vermeulen, Christopher Wild, Miquel Porta and Paolo Vineis

2) Strengthening the reporting of genetic risk prediction studies: the GRIPS statement (pages 1004–1009)
A. Cecile J. W. Janssens, John P. A. Ioannidis, Cornelia M. van Duijn, Julian Little and Muin J. Khoury, for the GRIPS Group

3) Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration (pages 1010–1035)
A. Cecile. J. W. Janssens, John P. A. Ioannidis, Sara Bedrosian, Paolo Boffetta, Siobhan M. Dolan, Nicole Dowling, Isabel Fortier, Andrew N. Freedman, Jeremy M. Grimshaw, Jeffrey Gulcher, Marta Gwinn, Mark A. Hlatky, Holly Janes, Peter Kraft, Stephanie Melillo, Christopher J. O’Donnell, Michael J. Pencina, David Ransohoff, Sheri D. Schully, Daniela Seminara, Deborah M. Winn, Caroline F. Wright, Cornelia M. van Duijn, Julian Little and Muin J. Khoury

4) Industry sponsorship and selection of comparators in randomized clinical trials (pages 172–182)
D. N. Lathyris, N. A. Patsopoulos, G. Salanti and J. P. A. Ioannidis

5) A catalogue of reporting guidelines for health research (pages 35–53)
I. Simera, D. Moher, J. Hoey, K. F. Schulz and D. G. Altman

6) Genetic risk information for common diseases may indeed be already useful for prevention and early detection (pages 56–63)
J. Gulcher and K. Stefansson

7) Personal genomics: information can be harmful (pages 64–68)
D. F. Ransohoff and M. J. Khoury

8) Feasibility and challenges of independent research on drugs: the Italian Medicines Agency (AIFA) experience (pages 69–86)
Italian Medicines Agency (AIFA) Research & Development Working Group

9) The effect of next-generation sequencing technology on complex trait research (pages 561–567)
Aaron G. Day-Williams and Eleftheria Zeggini

10) Assessing the incremental value of diagnostic and prognostic markers: a review and illustration
Ewout W. Steyerberg, Michael J. Pencina, Hester F. Lingsma, Michael W. Kattan, Andrew J. Vickers and Ben Van Calster